Your session is about to expire
← Back to Search
Image-Guided Radiation Therapy for Lung Cancer
Study Summary
This trial is testing a new way of delivering radiation dose by image-guided, intensity-modulated photon or proton beam radiation therapy to patients with stage II-IIIB non-small cell lung cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had radiation that could affect my heart, spine, or esophagus.I have chosen not to participate in this trial.My doctor thinks I can handle both chemotherapy and radiation at the same time.Your liver enzymes (ALT and AST) are not more than 2.5 times the normal level, or not more than 5 times the normal level if you have liver involvement.I am able to care for myself but may not be able to do active work.I've had initial chemotherapy and was then referred for combined chemotherapy and radiation.My lung function is good, with an FEV1 of at least 1 liter.My cancer's movement can be managed and tracked with specific CT scans, meeting the study's requirements.I have not had radiation therapy targeting the area around my heart and lungs.My lung cancer is at stage II-IIIB, or has come back after surgery or targeted radiation.Your bilirubin levels are not higher than 1.5 times the upper limit of normal.Your creatinine level is not more than 1.5 times the upper limit of normal.Your platelet count is at least 100,000 per cubic millimeter.Your hemoglobin level is at least 9.0 grams per deciliter.I have lost less than 15% of my weight in the 3 months before my diagnosis.My cancer has spread to my esophagus, spinal cord, major blood vessels, or heart.Your doctor can see the main tumor and nearby lymph nodes on a scan.You have enough infection-fighting white blood cells in your body.
- Group 1: Arm I (image-guided IMRT)
- Group 2: Arm II (image-guided IMPT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What results are investigators hoping to yield from this clinical investigation?
"The primary goal of this 6-month study is to identify the Maximum Tolerated Dose (MTD) for intensity modulated photon therapy (IMRT). Secondary outcomes include a change in symptom burden, evaluated through European Quality of Life Five Dimension [EQ-5D]) and MD Anderson Symptom Inventory [MDASI]-Plus Surveys via descriptive statistics and box plots. Additionally, progression free survival will be assessed using Kaplan and Meier's product limit estimator."
How many individuals have enrolled in this research initiative?
"Affirmative. According to clinicaltrials.gov, the trial is actively searching for volunteers; it was initially posted on September 17th 2012 and was last updated June 15th 2021. 100 individuals must be recruited from a single site."
Are there current opportunities for participation in this research project?
"Indeed, according to clinicaltrials.gov's records, this medical study is actively recruiting participants. The trial was launched on September 17th 2012 and updated last June 15th 2021. One hundred volunteers are required at one location for the duration of the research."
Share this study with friends
Copy Link
Messenger